Extracellular Vesicles Carry SARS-COV-2 Proteins Associated With Lower Antibody Production, Cardiovascular Complications, and Worse Outcomes in Patients With Severe COVID-19

• D. de Miguel Perez,
• M. Arroyo-Hernandez,
• S. Lasalvia,
• M. Gunasekaran,
• A. Cardona,
• S. Kaushal,
• D. Atanackovic,
• S. Sahoo,
• O. Arrieta,
• C. Rolfo

Affiliations

D. de Miguel Perez

Icahn School Of Medicine At Mount Sinai New York, New York, USA; Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, USA

M. Arroyo-Hernandez

Thoracic Oncology Unit, Instituto Nacional de Cancerología (INCan), Mexico City, Mexico

S. Lasalvia

Department of Cardiology, Icahn School of Medicine at Mount Sinai, New York, USA

M. Gunasekaran

Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, USA; Departments of Surgery and Pediatrics, Ann and Robert H. Lurie Children's Hospital of Chicago, Feinberg School of Medicine, Northwestern University, Chicago, USA

A. Cardona

Clinical and Translational Oncology Group, Clínica del Country, Bogota, Colombia

S. Kaushal

Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, USA; Departments of Surgery and Pediatrics, Ann and Robert H. Lurie Children's Hospital of Chicago, Feinberg School of Medicine, Northwestern University, Chicago, USA

D. Atanackovic

Transplant and Cellular Therapy Program, Department of Medicine, University of Maryland School of Medicine and Greenebaum Comprehensive Cancer Center, Baltimore, USA

S. Sahoo

Department of Cardiology, Icahn School of Medicine at Mount Sinai, New York, USA

O. Arrieta

Thoracic Oncology Unit, Instituto Nacional de Cancerología (INCan), Mexico City, Mexico

C. Rolfo

Icahn School Of Medicine At Mount Sinai New York, New York, USA; Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, USA